The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
Saved in:
| Date: | 2017 |
|---|---|
| Main Authors: | Yu. Lukianova, A. V. Andriiv, Ye. Kryzhanivska, V. F. Chekhun |
| Format: | Article |
| Language: | English |
| Published: |
2017
|
| Series: | Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001149650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)
by: Zavyalova, M., et al.
Published: (2016)
Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)
by: Kropyvko, S.V., et al.
Published: (2019)
Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)
by: N. O. Verovkina, et al.
Published: (2017)
Peculiarities of epidemiology and clinical-morphological characteristics of breast cancer in patients from different zones of Ivano-Frankivsk region
by: A. V. Andriiv, et al.
Published: (2015)
by: A. V. Andriiv, et al.
Published: (2015)
Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)
by: L. A. Nalieskina, et al.
Published: (2017)
Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome
by: Demash, D.V., et al.
Published: (2011)
by: Demash, D.V., et al.
Published: (2011)
Factors of prognosis in rectal cancer patients
by: B. B. Tataryn, et al.
Published: (2019)
by: B. B. Tataryn, et al.
Published: (2019)
Breast cancer: epidemiology, risk factors, pathogenesis, diagnosis, prognosis
by: S. E. Ragimzade
Published: (2017)
by: S. E. Ragimzade
Published: (2017)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)
by: L. A. Nalieskina, et al.
Published: (2018)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
by: V. F. Chekhun, et al.
Published: (2016)
by: V. F. Chekhun, et al.
Published: (2016)
Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer
by: Paliychuk, O.V., et al.
Published: (2018)
by: Paliychuk, O.V., et al.
Published: (2018)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Molecular subtypes of muscular invasive bladder canc
by: O. Sulaieva, et al.
Published: (2020)
by: O. Sulaieva, et al.
Published: (2020)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
by: D. E. Ryspaeva, et al.
Published: (2017)
by: D. E. Ryspaeva, et al.
Published: (2017)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014)
by: O. D. Ryabtseva, et al.
Published: (2014)
Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)
by: Chekhun, V.F., et al.
Published: (2023)
Immunohistochemical factors of endometrial cancer prognosis
by: A. A. Mikhanovskij, et al.
Published: (2018)
by: A. A. Mikhanovskij, et al.
Published: (2018)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: O. D. Ryabtseva, et al.
Published: (2013)
by: O. D. Ryabtseva, et al.
Published: (2013)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)
by: Ryabtseva, O.D., et al.
Published: (2013)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)
by: Atalay, C.
Published: (2013)
Similar Items
-
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016) -
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013) -
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013) -
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015) -
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)